Status:
COMPLETED
Clinical Study of Peripheral Capillary Oxygen Saturation (SpO2): Vital Signs Patch (VSP)
Lead Sponsor:
LifeWatch Services, Inc.
Conditions:
Desaturation of Blood
Eligibility:
All Genders
23-33 years
Phase:
NA
Brief Summary
A clinical study designed to determine the accuracy of the peripheral capillary oxygen saturation (SpO2) function of the Vital Signs Patch (VSP) device for measuring blood saturation level.
Detailed Description
The clinical study protocol was designed for determining the accuracy of the SpO2 function of the Vital Signs Patch device for measuring blood oxygen saturation level, according to the guidelines for ...
Eligibility Criteria
Inclusion
- Ages 23 to 33.
- Skin tone varied from light to dark.
Exclusion
- Smokers
- Anemic
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01899911
Start Date
March 1 2013
End Date
March 1 2013
Last Update
August 28 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Room M454, Moffitt Hospital, Box 0542, UCSF,
San Francisco, California, United States, CA 94143